Recall Record

Dartford, N/A, United Kingdom

Remel Europe Ltd. recalls

3 recalls recorded since 2018, most recently on 17 July 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)2
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
17 July 2026
Reason
Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2927-2026

Ongoing Class II Medical devices

Recall started
25 March 2026
Reason
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
Distribution
Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1923-2026

Terminated Class II Medical devices

Recall started
23 July 2020
Terminated
22 March 2022
Reason
Thermo Scientific" Remel" Bordetella pertussis Agglutinating Serum (R30165501/ZM10) is not performing, resulting in the potential for false negative results for serotypes 1 and 3
Distribution
Worldwide distribution - US Nationwide distribution including in the states of MO, CA and the countries of CA, AT, BO, CN, CZ, GB, GM, HK, IE, IT, MX, MY, NL,OM, SA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2920-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.